6th Annual Meeting of Health Technology Assessment International



	POST-CONFERENCE • Minister's Speech • Presentation Slides • Photos

Slides for Plenaries and Panels


	PL1	Globalisation and HTA - How Much Impact does Globalisation Have on Healthcare
		National Planning and Regulation under Pressure \| Akiko Maeda
		Industry Development and Provision of Technologies to a Global Market \| Clare McGRATH
		The Impact of Globalisation on Patients’ Expectations \| Angela COULTER
		Globalization as a Determinant of Health: Economics, Technology and Politics \| Ronald LABONTE
		Back to Top

	PL2	Global Variations in the Use and Application of HTA Findings in Decision Making: Science and Policy-Making in Action
		HTA Findings as Input to Decision Making: Malaysian Experience \| Rugayah BAKRI
		HTA in Comparative Effectiveness Research and Health Care Reform in the US \| Jean SLUTSKY
		Brazilian Experience on HTA Process \| FLAVIA Tavares Silva Elias
		Back to Top

	PL3	Globalisation and HTAi – Issues and Needs in Relation to HTA Closing Remarks
		Issues and Needs in Countries with Recently Established HTA in Asia \| TARN Yen-Huei, Tony
		Towards a Global HTA Governance \| Laura SAMPIETRO-COLOM
		Back to Top

	A1	Conflicts in HTA: Why They Occur, Why they are Important, and What Strategies are Available for Adjudication in Various Global Healthcare Settings
		Conflicts in Health Technology Assessment - A Perspective from a Developing Country \| Sivalal SADISIVAN
		Back to Top

	A3	Coverage with Evidence Development: What's Next?
		Coverage with Evidence Development \| Louis B. JACQUES
		Evidence-based Medicare coverage: Coverage with Evidence Development (CED) \| David MATCHAR
		Prospects for Coverage with Evidence Development \| Sean TUNIS
		Back to Top

	A4	What do We Learn from International Experiences with Appraisal Processes in Relation to the Final Reimbursement Advice?
		Appraisal in the Netherlands Work in progress \| Wim GOETTSCH
		Combining Cost-effectiveness and Severity of Disease Data for the Decision-making Process.\| Niklas HEDBERG
		Back to Top

	A5	The Socio-Economic Value of Medical Devices: Preliminary Evidence and Assessment Challenges
		Do financing systems take account of the value of medical devices? Evidence from the cardiovascular setting in Italy \| Giulia CAPPELLARO
		The Cost-Effectiveness of Coronary Stents in AMI Patients: Results from Germany \| Reinhard BUSSE
		Back to Top

	B1	HTA for Resource Allocation Decisions: Are Key Principles Relevant Globally?
		Application of the Key Principles to HTA Activities in Latin America \| Andres Pichon -RIVIERE
		Application of the Key Principles to HTA Activities in Taiwan \| TARN Yen-Huei,Tony
		Back to Top

	B2	Building Institutional and Technical Capacity for HTA in Developing Countries and Transitional Economies
		Building Structured Foundations for HTA in Eastern Europe \| Krzysztof LANDA
		Regional HTA Networks– Effective Way for Capacity Strengthening and Knowledge Sharing in latin America and Carribean \| Sivalal SADASIVAN
		Support for Capacity Building \| Karen RITCHIE
		Back to Top

	B3	Comparing Different Approaches to Ethical Inquiry in the Context of HTA. An Empirical Study
		The Ethics of HPV Vaccination: The Importance of Context \| Annette Braunack-MAYER
		Towards a More Uniform Approach in Addressing Ethical Issues in the Context of HTA: The EUnetHTA Core Model Experience on Bariatric Surgery \| Samuli SAARNI
		Back to Top

	B4	Working Together- HTA by Different Stakeholders
		Using Qualitative and Quantitative Modeling to Promote HTA \| David MATCHAR
		Interaction between Regulators and Payers \| Lloyd SANSOM
		Back to Top

	B5	Reallocating Resources in Health Care Systems: The Role of HTA Units in Identifying Existing Technologies of Low Added Value
		Re-evaluation of Existing Drugs in South Korea \| Eun-Young BAE
		Reallocating resources: an update of NICE activities \| Sarah GARNER
		Criteria for a Rational Disinvestment of Health Technologies in Hospitals \| Inaki Gutiérrez-IBARLUZEA
		Commencement of a NHMRC-funded Disinvestment Project in Australia: Plan, Aims and Objectives \| Adam ELSHAUG
		Back to Top

	B6	Telehealth Evidence: What is its Impact on Practice and Policy?
		Telehealth in Australia – Renal and Oncology \| Brendon KEARNEY
		Telehealth in the Basque Country and Spain \| Jose ASUA
		Telemental Health: Evidence, Policy and Practice \| David HAILEY
		Telehealth in Malaysia The Last 10 years \| Noormah DARUS
		Back to Top

	C1	HTA and HTA-based Decision-making: Going Global
		HTA in Australia: National and International Experiences \| Lloyd SANSOM
		HTA in the UK: 10 years of NICE experience \| David BARNETT
		Back to Top

	C3	Relying on Surrogate Outcomes in HTA: Concepts, Terms and Issues
		Transforming Surrogate Outcomes: an Australian Review \| Andrew MITCHELL
		Use in Surrogate Outcomes in HTA: Survey of UK reports \| Rod TAYLOR
		Considering the Cost-Effectiveness of Drugs based on Surrogate Outcomes: Recent Canadian Experience \| Don HUSEREAU
		Back to Top

	C4	Improving Drug Prescribing and Use: International Models for Evidence Uptake
		Improving Prescribing and Use of Medicines – Australian Model \| Lynn WEEKES
		Improving Drug Prescribing and Use: International Models for Evidence Uptake \| Barb SHEA
		Improving Drug Prescribing and Use: The Role of NICE \| Mirella MARLOW
		Back to Top

	C5	Minimum Requirements for a Documentation Unit in a HTA Agency. Skills, Resources and Communication Plans
		Knowledge and skills to be fulfilled in a documentation unit \| Malene Fabricius JENSEN
		Staff Ratios and Communication Needs: Improving the Diffusion and Impact of HTA Products, Perspective of the HTA Information Units \| Oriol Sola-MORALES
		Optimizing Resources. Information Resources to be Subscribed in a HTA Agency \| Inaki GUTIERREZ-IBARLUZEA
		Back to Top

	C6	Electronic Medical Records (EMR) - Worth the Cost or Just Over-Hyped?
		Clinical and Performance Outcomes: The Proven Value of Information Technology \| Tobias SAMO
		Back to Top

	D1	Health Technology Assessment of Influenza Pandemic Control Strategies: The Role of Vaccines and Neuraminidase Inhibitors
		Epidemiology of Influenza and Systematic Reviews of the Efficacy of Influenza Vaccine \| Lamberto MANZOLI
		Economic Evaluation of Influenza Pandemic Mitigation Strategies in the US \| Sander BEATE
		Back to Top

	D2	Adapting HTA for Use in Other Jurisdictions
		Adapting HTA for Use in Taiwan \| TARN Yen-Huei, Tony
		The Challenges for Adapting HTA For Use in Poland \| Iga LIPSKA
		One Agency, Thirteen Health Systems: Making HTA Relevant In A Decentralized Health System \| Don HUSEREAU
		Back to Top

	D3	Should Health Technology Assessments Value Labour Market Participation as a Clinical Outcome?: The Case for Early Intervention and Management of Musculoskeletal Disorders (MSDs) in the EU
		Fit For Work? Early Intervention & Labour Market Participation among European workers with MSDs \| Stephen BEVAN
		Productivity and the Wider Societal Perspective in HTA: Beyond MSDs \| Leela BARHAM
		Forecasting the Cost of Illness of RA in Italy: A Simulation Model \| Americo CICCHETTI
		Work Productivity and HTA: Are these Two Concepts Friends or Foes? \| Thomas MITTENDORF
		Back to Top

	D4	Impact of Including Patient Aspects in HTA
		Patient aspects in Danish HTAs – from Caesarean Section to Chronic Renal Failure \| Helga SIGMUND
		Patient Views on Wireless Capsule Endoscopy in Italy: Illuminating Safety and Acceptability \| Marco RATTI
		Smoking Cessation Programmes in Pregnancy: – What are Women’s Concerns? \| Sandy OLIVER
		Back to Top

	D5	Expanding Economic Evaluation in HTA - Can We Get More for Less?
		Expanding Economic Evaluation in HTA: Can We Get More for Less? \| Ivar Sønbø KRISTIANSEN
		Collaboration between HTA Agencies and Health Authorities: Ontario, Canada \| Murray KRAHN
		The Need for Collaboration Between Health Economists in HTA-Centres – How to Proceed? \| Torbjørn WISLOFF
		Back to Top

	D6	Emergency and Unscheduled Care: Coping with Demand, Providing Appropriate Care
		Measuring Performance in Emergency Care \| Janette TURNER
		International Cooperation in Provision of Emergency & Unscheduled Care: Opportunities and Barriers \| Michel BAER
		Information Systems in Emergency Care – Enabling an Appropriate Response and Performance Management \| Jerry OVERTON
		Back to Top

	E1	Health Technology Assessment in Middle-Income Countries
		The Role of Health Technology Assessment in Selected Middle-Income countries \| Wija OORTWIJN
		Principles of HTA Practice \| Rod TAYLOR
		Back to Top

	E2	Challenges and Opportunities for Assessment of and Access to Medical Devices and Diagnostics in Asia-Pacific
		Provider Payment Mechanism for Health Technology: Philippine Case \| Madeleine ROSAS-VALERA
		Back to Top

	E4	Supporting Healthcare Innovation Management by Comprehensive Early Assessment
		Supporting Healthcare Innovation Management by Comprehensive Early Assessment \| Bernhard BUHRLEN
		Requirements for Healthcare Innovations from the Public Health Perspective\| Finn Boerlum KRISTENSEN
		Approaches to Identify, Assess, and Manage Healthcare Innovations \| Iñaki GUTIERREZ-IBARLUZEA
		Managing Innovation in the Pharmaceutical Sector \| Clare McGRATH
		Early to Late Stage HTA in Cooperation with Medical Device Industries \| Lotte STEUTEN
		Back to Top

	E5	Scaling Up Health Service Delivery - What Resources are Needed: WHO Integrated Healthcare Technology Package (iHTP)
		Tools for Health Technology (HT) Planning: Using WHO's integrated Healthcare Technology Package (iHTP) To Improve Healthcare Quality and Delivery \| Peter HEIMANN, THOMAS JUDD
		Integrated Healthcare Technology Package: Scaling up Health Service Delivery \| Rosa CEBALLOS
		Back to Top

	E6	HPV Vaccination Policy in Different Settings: Any Role of HTA Evidence?
		New Technology Assessment in Taiwan – An Example on HPV Vaccination Evaluation \| Jasmine PWU
		HPV Vaccines Priorities and Timing \| Rabia KAHVECI
		The Role of HTA in the Development of HPV Vaccination Policy in Thailand \| Sripen TANTIVESS
		Cost-Effectiveness of HPV Vaccination in Japan \| Takashi FUKUDA
		Back to Top